BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1455395)

  • 1. Plasminogen levels in healthy volunteers--influence of age, sex, smoking and oral contraceptives.
    Tait RC; Walker ID; Conkie JA; Islam SI; McCall F; Mitchell R; Davidson JF
    Thromb Haemost; 1992 Nov; 68(5):506-10. PubMed ID: 1455395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasminogen activator inhibitor 1--a new thrombosis risk marker].
    Hoang NH; Kuntz BM; Brüster HT
    Dtsch Med Wochenschr; 1992 Jun; 117(26):1019-22. PubMed ID: 1618111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein C activity in healthy volunteers--influence of age, sex, smoking and oral contraceptives.
    Tait RC; Walker ID; Islam SI; McCall F; Conkie JA; Wight M; Mitchell R; Davidson JF
    Thromb Haemost; 1993 Aug; 70(2):281-5. PubMed ID: 8236135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is plasminogen deficiency a thrombotic risk factor? A study on 23 thrombophilic patients and their family members.
    Demarmels Biasiutti F; Sulzer I; Stucki B; Wuillemin WA; Furlan M; Lämmle B
    Thromb Haemost; 1998 Jul; 80(1):167-70. PubMed ID: 9684804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular diseases (CVD) risk factors, physical activity (PA) and plasma plasminogen (Plg) in a random sample of community-dwelling elderly.
    Kostka T; Para J; Kostka B
    Arch Gerontol Geriatr; 2009; 48(3):300-5. PubMed ID: 18374997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Profile of cardiovascular risk factors in females with a definitive myocardial infarct up to 49 years of age].
    Stammberger K; Schneider G
    Z Gesamte Inn Med; 1989 Mar; 44(6):177-9. PubMed ID: 2728560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Female sex and oral contraceptive use accelerate nicotine metabolism.
    Benowitz NL; Lessov-Schlaggar CN; Swan GE; Jacob P
    Clin Pharmacol Ther; 2006 May; 79(5):480-8. PubMed ID: 16678549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased heparin cofactor II levels in women taking oral contraceptives.
    Toulon P; Bardin JM; Blumenfeld N
    Thromb Haemost; 1990 Nov; 64(3):365-8. PubMed ID: 2096488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
    Hannaford PC; Kay CR
    Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term and long-term intra-individual variations and critical differences of coagulation parameters.
    Costongs GM; Bas BM; Janson PC; Hermans J; Brombacher PJ; van Wersch JW
    J Clin Chem Clin Biochem; 1985 Jul; 23(7):405-10. PubMed ID: 4045388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of salt consumption, physical activity, stress, tobacco and oral contraceptives in the epidemiology of essential hypertension].
    Gimeno Ortiz A; Jiménez Romano R; Ferrer Aguareles JL; Fernández Simón C
    Rev Sanid Hig Publica (Madr); 1990; 64(11-12):705-14. PubMed ID: 2131594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].
    Bauersachs R; Lindhoff-Last E; Ehrly AM; Kuhl H
    Zentralbl Gynakol; 1996; 118(5):262-70. PubMed ID: 8701622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Age and whole blood viscoelasticity. A risk factor study].
    Oder W; Kollegger H; Baumgartner C; Zeiler K; Oder B; Deecke L
    Acta Med Austriaca; 1991; 18 Suppl 1():71-4. PubMed ID: 1950394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use.
    Pomp ER; Rosendaal FR; Doggen CJ
    Am J Hematol; 2008 Feb; 83(2):97-102. PubMed ID: 17726684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.